pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
raps·Aug 17·1 min read
save

Experts suggest new safety framework to boost predictability of CNS toxicity assessments

Aug 17, 2026·read at raps ↗Neutral

A recent paper outlines a safety framework intended to make central nervous system (CNS) toxicity predictions more reliable during drug development.

The authors argue that new approach methodologies, including in vitro models and computational tools, together with artificial intelligence, can better capture neurological risk signals than traditional animal studies.

By standardizing how these digital and non-clinical methods are applied, the framework aims to improve interpretation of toxicity data and reduce uncertainty for developers and regulators.

source

This writeup was produced by pharmadog from original reporting by raps.

Original headline: “Experts propose safety framework for improving predictability, interpretation of CNS toxicity”

read at raps ↗
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Neurology6Psychiatry & CNS4

related stories

  • May 8Lilly, Gilead lead pharma’s M&A boomBioPharma Dive
  • May 8Dr Gruenbaum on Where Alternative Options to BTK Inhibitors Stand in MCLonclive
  • May 7Angelini to buy Catalyst in $4B play for rare neuro drugsBioPharma Dive
  • May 7Track the Lung Cancer Abstracts That are Gaining Attention at ASCO 2026onclive
  • May 7Reigniting Your Curiosity During Fellowshiponclive